# The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement

> **NCT06015711** · NA · RECRUITING · sponsor: **Ajou University School of Medicine** · enrollment: 96 (estimated)

## Conditions studied

- Opioid Use

## Interventions

- **DRUG:** Maxigesic administration

## Key facts

- **NCT ID:** NCT06015711
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-30
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015711, "The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06015711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
